9 Breast-conserving surgery after preoperative endocrine therapy versus chemotherapy in postmenopausal patients with estrogen-receptor-positive breast cancer

Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1731-8 ◽

2011 ◽

Vol 133 (1) ◽

pp. 145-159 ◽

Cited By ~ 12

Author(s):

Tokiko Ito ◽

Shinobu Kamijo ◽

Hiroto Izumi ◽

Kimitoshi Kohno ◽

Jun Amano ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Binding Protein ◽

Abstract PS12-25: Patterns of treatment and outcomes in real world patients with advanced estrogen receptor positive breast cancer receiving palbociclib and endocrine therapy

10.1158/1538-7445.sabcs20-ps12-25 ◽

2021 ◽

Author(s):

Lisa Prior ◽

Darko Skrobo ◽

Hazel Murray ◽

Abdul Rehman Farooq ◽

Anne Horgan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Real World ◽

P4-01-15: Alteration of Y-box Binding Protein-1 Expression Modifies the Response to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer.

10.1158/0008-5472.sabcs11-p4-01-15 ◽

2011 ◽

Author(s):

T Ito ◽

S Kamijo ◽

H Izumi ◽

K Kohno ◽

K-I Ito

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Binding Protein ◽

Abstract PD01-06: Inhibition of the Ret receptor tyrosine kinase in combination with endocrine therapy impacts on migration and metastatic potential of estrogen receptor positive breast cancer models.

10.1158/0008-5472.sabcs12-pd01-06 ◽

2012 ◽

Author(s):

NE Hynes ◽

A Gattelli ◽

I Nalvarte ◽

T Roloff

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tyrosine Kinase ◽

Endocrine Therapy ◽

Receptor Tyrosine Kinase ◽

Metastatic Potential ◽

Cancer Models ◽

Abstract OT2-01-01: Endocrine therapy alone as primary treatment for elderly patients with clinical stage I to III estrogen receptor positive breast cancer with low recurrence score

10.1158/1538-7445.sabcs15-ot2-01-01 ◽

2016 ◽

Author(s):

R Aft ◽

K Trinkaus ◽

C Ma

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Elderly Patients ◽

Endocrine Therapy ◽

Clinical Stage ◽

Recurrence Score ◽

Primary Treatment ◽

Stage I ◽

Abstract P6-03-09: Role of IL-6 in promoting endocrine therapy and palbociclib resistance estrogen receptor positive breast cancer cells

10.1158/1538-7445.sabcs19-p6-03-09 ◽

2020 ◽

Author(s):

Nicole M Kettner ◽

Tuyen Bui ◽

Xian Chen ◽

Kelly K Hunt ◽

Debu Tripathy ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Endocrine Therapy ◽

Breast Cancer Cells ◽

Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak

Annals of Surgery ◽

10.1097/sla.0000000000004027 ◽

2020 ◽

Vol 272 (2) ◽

pp. e96-e97 ◽

Cited By ~ 3

Author(s):

Carlie K. Thompson ◽

Minna K. Lee ◽

Jennifer L. Baker ◽

Deanna J. Attai ◽

Maggie L. DiNome

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Early Stage ◽

Neoadjuvant Endocrine Therapy ◽

Second Look ◽

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-9953-0 ◽

2008 ◽

Vol 113 (3) ◽

pp. 509-517 ◽

Cited By ~ 114

Author(s):

Farrokh Dehdashti ◽

Joanne E. Mortimer ◽

Kathryn Trinkaus ◽

Michael J. Naughton ◽

Matthew Ellis ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Predictive Biomarker ◽

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Breast Cancer Research ◽

10.1186/bcr2833 ◽

2011 ◽

Vol 13 (2) ◽

Cited By ~ 125

Author(s):

Cesar G Sanchez ◽

Cynthia X Ma ◽

Robert J Crowder ◽

Therese Guintoli ◽

Chanpheng Phommaly ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Phosphatidylinositol 3 Kinase ◽

Kinase Inhibition ◽

Positive Breast Cancer ◽

Phosphatidylinositol 3

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-0940-x ◽

2010 ◽

Vol 127 (1) ◽

pp. 43-51 ◽

Cited By ~ 89

Author(s):

F. Germán Rodríguez-González ◽

Anieta M. Sieuwerts ◽

Marcel Smid ◽

Maxime P. Look ◽

Marion E. Meijer-van Gelder ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Clinical Benefit ◽

Independent Predictor ◽

Expression Level ◽